Survival benefit associated with treating follicular lymphoma in patients 80 years or older

Albarmawi Husam; Onukwugha Eberechukwu; Keating Karen N.; Appukkuttan Sreevalsa; Yared Jean

首页> 外文期刊>Journal of geriatric oncology >Survival benefit associated with treating follicular lymphoma in patients 80 years or older

【24h】

Survival benefit associated with treating follicular lymphoma in patients 80 years or older

机译：80岁或以上患者治疗卵泡淋巴瘤的存活效果

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objectives: To evaluate the overall survival benefit associated with follicular lymphoma (FL)-directed therapy among patients diagnosed with FL at 80+ years.

机译：目的：评估与卵泡淋巴瘤（FL）患者的整体存活益处在80多年以上患者患者。

著录项

来源
《Journal of geriatric oncology》 |2020年第1期|共7页
作者
Albarmawi Husam; Onukwugha Eberechukwu; Keating Karen N.; Appukkuttan Sreevalsa; Yared Jean;
展开▼
作者单位

Univ Maryland Sch Pharm Dept Pharmaceut Hlth Serv Res 220 Arch St 12th Floor Baltimore MD;

Univ Maryland Sch Pharm Dept Pharmaceut Hlth Serv Res 220 Arch St 12th Floor Baltimore MD;

Bayer Healthcare Pharmaceut Inc Whippany NJ 07981 USA;

Bayer Healthcare Pharmaceut Inc Whippany NJ 07981 USA;

Univ Maryland Sch Med Greenebaum Comprehens Canc Ctr Baltimore MD 21201 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
Follicular lymphoma; Geriatric oncology; Survival analysis; Cancer treatment;

机译：卵泡淋巴瘤;老年肿瘤学;存活分析;癌症治疗;

相似文献

外文文献
中文文献
专利

1. Survival benefit associated with treating follicular lymphoma in patients 80 years or older [J] . Albarmawi Husam, Onukwugha Eberechukwu, Keating Karen N., Journal of geriatric oncology . 2020,第1期

机译：80岁或以上患者治疗卵泡淋巴瘤的存活效果
2. Durable benefit of rituximab maintenance post-autograft in patients with relapsed follicular lymphoma: 12-year follow-up of the EBMT lymphoma working party Lym1 trial [J] . Pettengell R., Uddin R., Boumendil A., Bone marrow transplantation . 2021,第6期

机译：Rituximab维护的耐用益处自体移植患者复发卵瘤患者：12年的EBMT淋巴瘤工作党的LYM1试验
3. Obinutuzumab-Based Immunochemotherapy Prolongs Progression-Free Survival and Time to Next Anti-Lymphoma Treatment in Patients with Previously Untreated Follicular Lymphoma: Four-Year Results from the Phase III GALLIUM Study [J] . Townsend William, Buske Christian, Cartron Guillaume, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：基于obInutuzumab的免疫化疗法延长了患有先前未经处理的滤泡淋巴瘤患者的无进展的存活和时间，患者：III期镓研究的四年结果
4. Identification of Genes Important in Predicting the Overall Survival in Patients with Follicular Lymphoma [C] . Li Xiao, Kai Fu, Javeed Iqbal, International Conference on Data Mining . 2005

机译：鉴定卵腔淋巴瘤患者总生存的基因重要性
5. Computer Use Among Seniors 80 Years and Older: Narrative Inquiry on the Benefits and Problems [D] . Swartz, Nancy P. 2012

机译：80岁及以上老年人的计算机使用：对收益和问题的叙述性询问
6. Fc gamma receptor 3a genotype in follicular lymphoma: the end of the story? Reply to Fc gamma receptor 3a genotype predicts overall survival in follicular lymphoma patients treated on SWOG trials with combined monoclonal antibody plus chemotherapy but not chemotherapy alone. Haematologica. 2012;97(6):937-942 [O] . Vít Procházka, Jana Gazdová, Tomáš Papajík 2012

机译：滤泡性淋巴瘤中的Fcγ受体3a基因型：故事的结局？答复 Fcγ受体3a基因型预测在SWOG试验中接受联合单克隆抗体加化学疗法而非仅化学疗法治疗的滤泡性淋巴瘤患者的总体生存率。血液学。 2012; 97（6）：937-942
7. Durable Complete Remission and Long-Term Survival in FDG-PET Staged Patients with Stage III Follicular Lymphoma, Treated with Wide-Field Radiation Therapy [O] . Michael P. MacManus, Rodney J. Hicks, Mathias Bressel, 2020

机译：FDG-PET分级患者III型卵泡淋巴瘤患者的耐用完全缓解和长期存活，用广泛的辐射治疗治疗

Survival benefit associated with treating follicular lymphoma in patients 80 years or older

摘要

著录项

相似文献

相关主题

期刊订阅